Age of the Cell - A Cure for What Ails the American Healthcare System?
"Sometimes decades go by and nothing happens. Sometimes weeks go by and decades happen."
Vladimir Lenin was most likely discussing changes in social structures and political systems when he wrote this, but the statement may amply apply to the situation now slowly developing, building up like a seemingly dormant volcano, in the American healthcare system. Prices for treatments are rising, medicines
Updated 03-08-2014 at 04:31 AM by sgottenyc
March 1, 2014
Post 30 – Road to a Million,
Well the last post started out with the New England Journal of Medicine was to report results of the ACT trials. Well not sure what the hold up is but so far its not been posted. Till this initial results get posted and published, ACTC stock value will sit pretty much where it is.
So what is going on? Why the silence, why so quiet? A number of presentations have happened, and not much
January 26, 2014
Post 29 – Road to a Million,
OMG everyone, It has been announced that the New England Journal of Medicine will report the results of the ACT Clinical Trials for AMD and Stargardts!! There was a conference in Rome Saturday and the announcement was made there. Generally these announcements are allowed just before the results are published. The next printing of the Journal is Wednesday January 29th!!
This is the link to the conference that happened
The first time I believed ACT was on the brink of worldwide acclaim lured ahead of the first approval and subsequent injections. The second time I rejoiced prior to the Lancet, which continued on throughout the 2012 ASM time period.
My visceral objections were subsided by thoughts of clinical celerity. Looking back, ACT was nothing more than a babushka doll fashioned as a paragon of the biotech industry.
Here I was, still anticipating hysteria at any moment. With
Updated 01-21-2014 at 10:53 PM by Wallace907
The Japanese proposed trial on RPEs ARE NOT THE TRIALS OR EVEN CLOSE TO BEING EQUIVALENT TO WHAT LANZA/ACTC ARE DOING!
IT IS IN FACT A "PRE-CLINICAL" USING HUMANS. AND NO FOUNDATION OF SAFETY PROFILE TO BEGIN WITH!
The process being used by Rikken is an "Exemption Process" that goes around Japan's Established Trial Standards.THIS WOULD NEVER HAVE HAPPENED IN THE US.
IT IS AN EXPERIMENT!
I personally, do not have any issues with it. What
Copyright © 2013 InvestorStemcell.com - All Rights ReservedContent Relevant URLs by vBSEO 3.6.0 PL2
Website design by: Relivo Media